Mylan Inc. Fourth Quarter 2013 Adjusted Diluted EPS Increases 20% To $0.78 And Full Year Adjusted Diluted EPS Increases 12% To $2.89

Published: Feb 27, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

PITTSBURGH, Feb. 27, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced its financial results for the three months and year ended December 31, 2013.

Financial Highlights

-- Adjusted diluted EPS of $0.78 for the three months ended December 31, 2013 compared to $0.65 for the same prior year period, an increase of 20%

Help employers find you! Check out all the jobs and post your resume.

Back to news